3-n-methylspiperone has been researched along with Chronic Illness in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dannals, RF; Pearlson, G; Ravert, HT; Sapp, J; Shaya, EK; Strauss, M; Tune, LE; Wilson, AA; Wong, DF; Young, T | 1 |
1 other study(ies) available for 3-n-methylspiperone and Chronic Illness
Article | Year |
---|---|
Dopamine D2 receptor density estimates in schizophrenia: a positron emission tomography study with 11C-N-methylspiperone.
Topics: Adult; Carbon Radioisotopes; Chronic Disease; Cohort Studies; Corpus Striatum; Dopamine Agents; Female; Humans; Male; Psychiatric Status Rating Scales; Receptors, Dopamine D2; Schizophrenia; Schizophrenic Psychology; Spiperone; Tomography, Emission-Computed | 1993 |